Humanigen, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported revenue was USD 0.221 million compared to USD 1.04 million a year ago. Net loss was USD 23.69 million compared to USD 66.74 million a year ago. Basic loss per share from continuing operations was USD 0.23 compared to USD 1.12 a year ago.
For the nine months, revenue was USD 2.29 million compared to USD 2.56 million a year ago. Net loss was USD 75.12 million compared to USD 203.11 million a year ago. Basic loss per share from continuing operations was USD 0.95 compared to USD 3.56 a year ago.